MECC 18th Annual California Cancer Consortium Conference 2022

Regular price
$10.00
Sale price
$10.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

Meetings Events & Conference Coordinators 18th Annual California Cancer Consortium Conference 2022

Format: 26 videos, size: 2.17 GB

Course Audience: oncologist

Overview:

  • Start: 19 August 2022
  • End: 21 August 2022

This educational meeting was developed in cooperation with the academic faculty and scientists belonging to the California Cancer Consortium to provide an annual in-depth exposure and review of new advances in cancer drug development, biology, biomarkers, diagnosis, and therapy. The agenda and format are specifically designed to address knowledge gaps identified from prior course participant evaluations and unsolicited comments from practicing oncologists (from private practice, academia) as well as scientists involved in cancer clinical trials. This area of knowledge will be best addressed by an in-depth conference on systemic therapy of malignancies (both solid and hematologic), with ample time provided for interaction by attendees with expert faculty. It is expected that this educational activity will enhance the clinical competence of clinicians and the healthcare team in managing the care of the cancer patient, and subsequently, improve patient outcomes.

This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together the interprofessional team that includes, respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances. Topics focus on the major cancers and drug development areas, including signal transduction/CDK inhibition, angiogenesis inhibition, PI3K/mTOR inhibition, antibody-drug conjugates, and immunotherapy, among others. This annual conference also includes interactive roundtable discussion forums with participation of cancer care experts from the California Cancer Consortium, and features renowned professionals from academia, patient advocacy, government, payer, industry, and business realms of cancer care.

Adjuvant Therapy in Breast Cancer State of the Art (Video MP4 Format)

Advance in Treatment of Acute Lymphocyctic Leukemia (Video MP4 Format)

Advanced Breast Cancer State of the Art (Video MP4 Format)

Advances in Car-T Cells and Other Cellular Based Therapies (Video MP4 Format)

Advances in Small Cell Lung Cancer and Mesothelioma (Video MP4 Format)

Advances in the Treatment of CNS Malignancies (Video MP4 Format)

AML and MDS Current Status and Future Directions (Video MP4 Format)

Bayesian Designs in Clinical Trials (Video MP4 Format)

Castration Resistant Prostate Cancer What is the Optimal Treatment (Video MP4 Format)

Colorectal Cancer State of the Art (Video MP4 Format)

Esophageal and Gastric Cancer New Developments (Video MP4 Format)

Genomics and Cancer Disparities (Video MP4 Format)

Hepatocellular and Biliary Cancers Recent Advances (Video MP4 Format)

How I Treat Locally Advanced Head and Neck Cancer (Video MP4 Format)

How I Treat Multiple Myeloma (Video MP4 Format)

Lymphoma State of the Art (Video MP4 Format)

Management of Immune Related Adverse Events (Video MP4 Format)

Pancreatic Cancer Emerging Strategies (Video MP4 Format)

PK and PD Considerations in Early Phase Clinical Trials (Video MP4 Format)

Renal Cell Cancer Recent Advances (Video MP4 Format)

State of the Art Hormone-sensitive Prostate Cancer (Video MP4 Format)

The Future of Biomarkers of Immunotherapy in Cancer (Video MP4 Format)

The Future of Combined Modality Therapy (Video MP4 Format)

Updates in Immunotherapy for Lung Cancer (Video MP4 Format)

Updates in Targeted Therapy for NSCLC (Video MP4 Format)

Updates in Treatment of Early Stage and Locally Advanced NSCLC (Video MP4 Format)

Go to full site